Literature DB >> 16923317

Prevention of postlaryngectomy pharyngocutaneous fistula using a sternocleidomastoid muscle collar flap.

O A Albirmawy1.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the efficacy of a sternocleidomastoid muscle collar flap in the prevention of pharyngocutaneous fistula in patients who had undergone total laryngectomy. STUDY
DESIGN: Retrospective clinical study.
SETTING: Otolaryngology department, Tanta University, Egypt.
METHODS: Sixty-five consecutive total laryngectomy procedures performed between October 1999 and October 2005 were reviewed. The fistula rate in laryngectomy patients operated on prior to 2002, without sternocleidomastoid collar flap creation (group A) was compared with that of patients operated on after October 2002, at which time this flap was introduced for routine use during primary surgery (group B).
RESULTS: In group A, the incidence of pharyngocutaneous fistula was 12 in 35 (34 per cent) while its incidence in group B was 1 in 30 (3.3 per cent). On analysis, the risk factors within both the groups were essentially similar.
CONCLUSION: The routine addition of a superiorly based sternal head of sternocleidomastoid muscle flap on one or both sides to cover the repaired pharynx during surgery reduced the incidence of postlaryngectomy pharyngocutaneous fistula, patient morbidity and mortality, and hospital stay; voice rehabilitation and swallowing were also improved.

Entities:  

Mesh:

Year:  2006        PMID: 16923317     DOI: 10.1017/S0022215106002659

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Sternocleidomastoid flap augmentation of the pharyngeal closure after total laryngectomy.

Authors:  Sherif Gabr Ibrahim; Basim Metwally Wahba; Ahmed Mahmoud Elbatawi; Ahmad Mohamed Eltelety
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-15       Impact factor: 2.503

2.  Pharyngocutaneous fistula: the incidence and the risk factors.

Authors:  Robert Šifrer; Aleksandar Aničin; Maja Perme Pohar; Miha Žargi; Peter Pukl; Tanja Soklič; Primož Strojan
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-08       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.